Global Blood Bank Analyzer Market

Market Research Methodology

• 2.1. Research methodology and design

• 2.2. Sample selection

• 2.3. Reliability and validity

Market Analysis

• 3.1. Market size and growth rates

• 3.2. Macroeconomic change

• 3.3. Market growth drivers, market dynamics and trends

• 3.4. Megatrends and their impact

• 3.5. Change and strategic drift

• 3.6. Characteristics mapping

• 3.7. Value chain analysis

• 3.8. Distribution platforms

• 3.9. Market scenarios and opportunity forecasts

• 3.10. Geographic analysis

• 3.11. Relevant markets

• 3.12. The new frontiers of growth

• 3.13. Creating value through sustainable strategies

Market Breakdown by Product Type

• 4.1. Introduction

• 4.2. Automated Analyzers

• 4.3. Semi-Automated Analyzers

• 4.4. Manual Analyzers

Market Breakdown by Test Type

• 5.1. Introduction

• 5.2. Blood Typing and Crossmatching

• 5.3. Infectious Disease Screening

• 5.4. Antibody Screening and Identification

Market Breakdown by End User

• 6.1. Introduction

• 6.2. Blood Banks

• 6.3. Hospitals

• 6.4. Clinical Laboratories

• 6.5. Emergency Services

• 6.6. Research Institutions

Market Breakdown by Geography

• 7.1. North America

• 7.1.1. U.S.

• 7.1.2. Canada

• 7.1.3. Mexico

• 7.2. South America

• 7.2.1. Brazil

• 7.2.2. Argentina

• 7.2.3. Others

• 7.3. Europe

• 7.3.1. Germany

• 7.3.2. France

• 7.3.3. U.K.

• 7.3.4. Russia

• 7.3.5. Italy

• 7.3.6. Spain

• 7.3.7. Sweden

• 7.3.8. Belgium

• 7.3.9. Denmark

• 7.3.10. Austria

• 7.3.11. Switzerland

• 7.3.12. Netherlands

• 7.3.13. Others

• 7.4. Asia-Pacific

• 7.4.1. China

• 7.4.2. Japan

• 7.4.3. South Korea

• 7.4.4. India

• 7.4.5. Australia

• 7.4.6. Others

• 7.5. Middle East & Africa

• 7.5.1. South Africa

• 7.5.2. Saudi Arabia

• 7.5.3. UAE

• 7.5.4. Israel

• 7.5.5. Others

Competitive Landscape

• 8.1. Low-cost position

• 8.2. Competitive situation and trends

• 8.3. Competitive strategies

• 8.4. Marketing strategies

• 8.5. Industry benchmarking

• 8.6. Maintaining current market share

• 8.7. Expansion path

• 8.8. Recent market and industry developments

• 8.8.1. New product developments and announcements

• 8.8.2. Agreements, partnerships, joint ventures, and collaborations

• 8.8.3. Mergers and acquisitions and major PE deals

Companies Profiled

• 9.1. Abbott

• 9.2. BD (Becton, Dickinson)

• 9.3. BioMerieux

• 9.4. Bio-Rad Laboratories, Inc.

• 9.5. Fujirebio

• 9.6. Hologic

• 9.7. Immucor (Werfen)

• 9.8. Ortho Clinical Diagnostics (OCD)

• 9.9. Siemens Healthcare GmbH

• 9.10. Thermo Fisher Scientific